New compound shows promise against treatment-resistant prostate cancers...

[Fiddler2004]

UC Davis Health researchers have developed a new compound that could offer alternatives for patients with treatment-resistant tumors. The molecule is called LX-1. It simultaneously targets androgen receptor (AR) variants and the enzyme AKR1C3, which are both known to drive resistance.... bit.ly/3jNG1aY

Good read 🙏

[6357axbz]

guess we’ll see in a few years

[Fiddler2004 in reply to 6357axbz]

I hope it works out... Looks promising 😊